USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
05-Oct-2018
North America
Market Research
9AB9-00-A9-00-00
HC03093-NA-MR_22418
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the outcome of diagnosis is time-bound, the test accuracy—sensitivity and specificity—plays a key role in determining the disease type, which is vital for delivering enhanced patient care and represents a major challenge. Point-of-care diagnostic testing (POCT) has the potential to rapidly identify the infectious diseases and provide actionable information to improve disease management, especially in resource-limited settings.
The current challenges faced by the industry include efficiency of test accuracy, requirement for additional confirmatory test in laboratory, improper handling of patient samples, which may lead to errors and reimbursement cuts by Medicare and Medicaid. However, drivers such as technological innovation, expansion of CLIA-waived simple tests, and funding from research organization and NGOs have provided a strong impetus to the growth of the POCT market. With the synergistic effect of advanced technologies, such as chip-based PCR technique, fluid-phase immunoprecipitation assays, new multiplexing ecosystems, and smartphone-based POCT, the growth is anticipated to increase rapidly in the next 5 years.
Research Scope
The key objective of this growth insight for infectious disease POCT study is to highlight the current market dynamics such as key market participants, market segments, and evolving business opportunities. The study aims to identify enterprises that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue and insights into key technological segments and disease areas. It covers the key drivers, challenges in the market impeding growth, competitive landscape, market participant strategies, and future growth strategies.
Research Highlights
The study also highlights growth opportunities, key trends, mergers and acquisitions, notable partnerships, collaboration opportunities, and key companies to watch. The study is focused on the United States. Major participants mentioned in the study are Abbott, Quidel, Meridian, OraSure, Roche, GenMark, and Cepheid.
Key Issues Addressed
- What are the biggest opportunities for companies in the infectious disease point of care testing space?
- What are the key factors that would drive the market and how will the segments evolve or change?
- What are the total market size and the projected growth of POCT solutions for infectious diseases?
- What are the emerging technological building blocks contributing to the future functionality of POCTs?
- Which areas of POCT should category leaders consider for future growth and expansion?
Key Findings
Scope and Segmentation
Key Questions Addressed in this Study
Big Market Themes
Future Trends—Three Big Predictions
Market Background and Overview
Market Background and Overview (continued)
POCT Reimbursement
Competitor Portfolio Focus Area—Infectious Disease
Key Mergers, Acquisitions, and Partnership Assessment
Key Companies to Watch
Key Market Drivers
Market Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Discussion
Market Breakdown by Technology
Market Share by Top Competitors
Key Infectious Disease Segments
Key Infectious Disease Segments (continued)
Visioning Scenarios for the Infectious Disease POCT Market
Key Technology Trends in Infectious Disease POCT
Future Technology Trends in Infectious Disease POCT
Growth Opportunity 1—Design Simplicity, Miniaturized and High Accuracy of Molecular Point of Care Tests to Provide Growth Opportunity
Growth Opportunity 1—Design Simplicity, Miniaturized and High Accuracy of Molecular Point of Care Tests to Provide Growth Opportunity (continued)
Growth Opportunity 2—Reemergence of Diseases Such as Sepsis, Hepatitis A and Incidence of New Forms of Influenza Such as H1, H3, and H7 Strains Would Provide Opportunity to Expand Product Pipeline
Growth Opportunity 3—Companies Expanding from Centralized to Decentralized CLIA-based Setting to Experience Growth Opportunity
Growth Opportunity Matrix
Strategic Imperatives for the Infectious Disease POCT Market
Future Trends—Three Big Predictions
Legal Disclaimer
Competitive Product Matrix for Key Infectious Diseases
Competitive Product Matrix for Key Infectious Diseases (continued)
Competitive Product Matrix for Key Infectious Diseases (continued)
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The key objective of this growth insight for infectious disease POCT study is to highlight the current market dynamics such as key market participants, market segments, and evolving business opportunities. The study aims to identify enterprises that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue and insigh
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Supratik Paul |
| Industries | Healthcare |
| WIP Number | 9AB9-00-A9-00-00 |
| Is Prebook | No |
| GPS Codes | 9562-B1,9600-B1,9627-B1,9837-B1,9A43-B1,9A44-B1,9A47-B1,9A4B-B1 |
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
$1,500.00
Special Price $1,125.00 save 25 %